-
1
-
-
0033526176
-
P-glycoprotein, a gatekeeper in the blood-brain barrier
-
Schinkel AH: P-glycoprotein, a gatekeeper in the blood-brain barrier. Adv Drug Deliv Rev 1999, 36:179-194.
-
(1999)
Adv Drug Deliv Rev
, vol.36
, pp. 179-194
-
-
Schinkel, A.H.1
-
2
-
-
0034811880
-
Isolation of endothelial cells from brain, lung, and kidney: Expression of the multidrug resistance P-glycoprotein isoforms
-
Demeule M, Labelle M, Regina A, Berthelet F, Beliveau R: Isolation of endothelial cells from brain, lung, and kidney: expression of the multidrug resistance P-glycoprotein isoforms. Biochem Biophys Res Commun 2001, 281:827-834.
-
(2001)
Biochem Biophys Res Commun
, vol.281
, pp. 827-834
-
-
Demeule, M.1
Labelle, M.2
Regina, A.3
Berthelet, F.4
Beliveau, R.5
-
3
-
-
3242785620
-
Importance of P-glycoprotein at blood-tissue barriers
-
Fromm MF: Importance of P-glycoprotein at blood-tissue barriers. Trends Pharmacol Sci 2004, 25:423-429.
-
(2004)
Trends Pharmacol Sci
, vol.25
, pp. 423-429
-
-
Fromm, M.F.1
-
4
-
-
4644292545
-
Potential role of ABC transporters as a detoxification system at the blood-CSF barrier
-
de Lange EC: Potential role of ABC transporters as a detoxification system at the blood-CSF barrier. Adv Drug Deliv Rev 2004, 56:1793-1809.
-
(2004)
Adv Drug Deliv Rev
, vol.56
, pp. 1793-1809
-
-
de Lange, E.C.1
-
5
-
-
12344262373
-
Blood-brain barrier active efflux transporters: ATPbinding cassette gene family
-
Loscher W, Potschka H: Blood-brain barrier active efflux transporters: ATPbinding cassette gene family. NeuroRx 2005, 2:86-98.
-
(2005)
NeuroRx
, vol.2
, pp. 86-98
-
-
Loscher, W.1
Potschka, H.2
-
6
-
-
0036797713
-
Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans
-
Vogelgesang S, Cascorbi I, Schroeder E, Pahnke J, Kroemer HK, Siegmund W, Kunert-Keil C, Walker LC, Warzok RW: Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans. Pharmacogenetics 2002, 12:535-541.
-
(2002)
Pharmacogenetics
, vol.12
, pp. 535-541
-
-
Vogelgesang, S.1
Cascorbi, I.2
Schroeder, E.3
Pahnke, J.4
Kroemer, H.K.5
Siegmund, W.6
Kunert-Keil, C.7
Walker, L.C.8
Warzok, R.W.9
-
7
-
-
33646241523
-
Cerebrovascular P-glycoprotein expression is decreased in Creutzfeldt-Jakob disease
-
Vogelgesang S, Glatzel M, Walker LC, Kroemer HK, Aguzzi A, Warzok RW: Cerebrovascular P-glycoprotein expression is decreased in Creutzfeldt-Jakob disease. Acta Neuropathol 2006, 111:436-443.
-
(2006)
Acta Neuropathol
, vol.111
, pp. 436-443
-
-
Vogelgesang, S.1
Glatzel, M.2
Walker, L.C.3
Kroemer, H.K.4
Aguzzi, A.5
Warzok, R.W.6
-
8
-
-
46649085260
-
Decreased blood-brain barrier Pglycoprotein function in the progression of Parkinson's disease, PSP and MSA
-
Bartels AL, Willemsen AT, Kortekaas R, de Jong BM, de VR, de KO, van Oostrom JC, Portman A, Leenders KL: Decreased blood-brain barrier Pglycoprotein function in the progression of Parkinson's disease, PSP and MSA. J Neural Transm 2008, 115:1001-1009.
-
(2008)
J Neural Transm
, vol.115
, pp. 1001-1009
-
-
Bartels, A.L.1
Willemsen, A.T.2
Kortekaas, R.3
de Jong, B.M.4
De, V.R.5
de, K.O.6
van Oostrom, J.C.7
Portman, A.8
Leenders, K.L.9
-
9
-
-
84863393540
-
-
Brain, doi: 10.1093/brain/awr298
-
van Assema DM, Lubberink M, Bauer M, van der Flier WM, Schuit RC, Windhorst AD, Comans EF, Hoetjes NJ, Tolboom N, Langer O, Müller M, Scheltens P, Lammertsma AA, van Berckel BNM: Blood-brain barrier Pglycoprotein function in Alzheimer's disease. Brain 2011, doi: 10.1093/brain/awr298.
-
(2011)
Blood-brain barrier Pglycoprotein function in Alzheimer's disease
-
-
van Assema, D.M.1
Lubberink, M.2
Bauer, M.3
van der Flier, W.M.4
Schuit, R.C.5
Windhorst, A.D.6
Comans, E.F.7
Hoetjes, N.J.8
Tolboom, N.9
Langer, O.10
Müller, M.11
Scheltens, P.12
Lammertsma, A.A.13
van Berckel, B.N.M.14
-
10
-
-
34548413773
-
Pharmacoresistance in epilepsy: A pilot PET study with the Pglycoprotein substrate R-[(11)C]verapamil
-
Langer O, Bauer M, Hammers A, Karch R, Pataraia E, Koepp MJ, Abrahim A, Luurtsema G, Brunner M, Sunder-Plassmann R, Zimprich F, Joukhadar C, Gentzsch S, Dudczak R, Kletter K, Müller M, Baumgartner C: Pharmacoresistance in epilepsy: a pilot PET study with the Pglycoprotein substrate R-[(11)C]verapamil. Epilepsia 2007, 48:1774-1784.
-
(2007)
Epilepsia
, vol.48
, pp. 1774-1784
-
-
Langer, O.1
Bauer, M.2
Hammers, A.3
Karch, R.4
Pataraia, E.5
Koepp, M.J.6
Abrahim, A.7
Luurtsema, G.8
Brunner, M.9
Sunder-Plassmann, R.10
Zimprich, F.11
Joukhadar, C.12
Gentzsch, S.13
Dudczak, R.14
Kletter, K.15
Müller, M.16
Baumgartner, C.17
-
11
-
-
49649128693
-
Blood-brain barrier P-glycoprotein function is not impaired in early Parkinson's disease
-
Bartels AL, van Berckel BN, Lubberink M, Luurtsema G, Lammertsma AA, Leenders KL: Blood-brain barrier P-glycoprotein function is not impaired in early Parkinson's disease. Parkinsonism Relat Disord 2008, 14:505-508.
-
(2008)
Parkinsonism Relat Disord
, vol.14
, pp. 505-508
-
-
Bartels, A.L.1
van Berckel, B.N.2
Lubberink, M.3
Luurtsema, G.4
Lammertsma, A.A.5
Leenders, K.L.6
-
12
-
-
69249215171
-
Age dependency of cerebral P-gp function measured with (R)-[11C]verapamil and PET
-
Bauer M, Karch R, Neumann F, Abrahim A, Wagner CC, Kletter K, Muller M, Zeitlinger M, Langer O: Age dependency of cerebral P-gp function measured with (R)-[11C]verapamil and PET. Eur J Clin Pharmacol 2009, 65:941-946.
-
(2009)
Eur J Clin Pharmacol
, vol.65
, pp. 941-946
-
-
Bauer, M.1
Karch, R.2
Neumann, F.3
Abrahim, A.4
Wagner, C.C.5
Kletter, K.6
Muller, M.7
Zeitlinger, M.8
Langer, O.9
-
13
-
-
77950952797
-
P-glycoprotein function at the blood-brain barrier in humans can be quantified with the substrate radiotracer 11C-Ndesmethyl-loperamide
-
Kreisl WC, Liow JS, Kimura N, Seneca N, Zoghbi SS, Morse CL, Herscovitch P, Pike VW, Innis RB: P-glycoprotein function at the blood-brain barrier in humans can be quantified with the substrate radiotracer 11C-Ndesmethyl-loperamide. J Nucl Med 2010, 51:559-566.
-
(2010)
J Nucl Med
, vol.51
, pp. 559-566
-
-
Kreisl, W.C.1
Liow, J.S.2
Kimura, N.3
Seneca, N.4
Zoghbi, S.S.5
Morse, C.L.6
Herscovitch, P.7
Pike, V.W.8
Innis, R.B.9
-
14
-
-
66149123753
-
Human brain imaging and radiation dosimetry of 11C-N-desmethyl-loperamide, a PET radiotracer to measure the function of P-glycoprotein
-
Seneca N, Zoghbi SS, Liow JS, Kreisl W, Herscovitch P, Jenko K, Gladding RL, Taku A, Pike VW, Innis RB: Human brain imaging and radiation dosimetry of 11C-N-desmethyl-loperamide, a PET radiotracer to measure the function of P-glycoprotein. J Nucl Med 2009, 50:807-813.
-
(2009)
J Nucl Med
, vol.50
, pp. 807-813
-
-
Seneca, N.1
Zoghbi, S.S.2
Liow, J.S.3
Kreisl, W.4
Herscovitch, P.5
Jenko, K.6
Gladding, R.L.7
Taku, A.8
Pike, V.W.9
Innis, R.B.10
-
15
-
-
70349451693
-
Imaging the function of P-glycoprotein with radiotracers: Pharmacokinetics and in vivo applications
-
Kannan P, John C, Zoghbi SS, Halldin C, Gottesman MM, Innis RB, Hall MD: Imaging the function of P-glycoprotein with radiotracers: pharmacokinetics and in vivo applications. Clin Pharmacol Ther 2009, 86:368-377.
-
(2009)
Clin Pharmacol Ther
, vol.86
, pp. 368-377
-
-
Kannan, P.1
John, C.2
Zoghbi, S.S.3
Halldin, C.4
Gottesman, M.M.5
Innis, R.B.6
Hall, M.D.7
-
16
-
-
77957998294
-
Using PET studies of P-gp function to elucidate mechanisms underlying the disposition of drugs
-
Syvanen S, Hammarlund-Udenaes M: Using PET studies of P-gp function to elucidate mechanisms underlying the disposition of drugs. Curr Top Med Chem 2010, 10:1799-1809.
-
(2010)
Curr Top Med Chem
, vol.10
, pp. 1799-1809
-
-
Syvanen, S.1
Hammarlund-Udenaes, M.2
-
17
-
-
16644362795
-
Stereoselective firstpass metabolism of highly cleared drugs: Studies of the bioavailability of l-and d-verapamil examined with a stable isotope technique. 1984
-
Vogelgesang B, Echizen H, Schmidt E, Eichelbaum M: Stereoselective firstpass metabolism of highly cleared drugs: studies of the bioavailability of l-and d-verapamil examined with a stable isotope technique. 1984. Br J Clin Pharmacol 2004, 58:S796-S803.
-
(2004)
Br J Clin Pharmacol
, vol.58
-
-
Vogelgesang, B.1
Echizen, H.2
Schmidt, E.3
Eichelbaum, M.4
-
18
-
-
33744936006
-
Effect of age on functional P-glycoprotein in the blood-brain barrier measured by use of (R)-[(11)C]verapamil and positron emission tomography
-
Toornvliet R, van Berckel BN, Luurtsema G, Lubberink M, Geldof AA, Bosch TM, Oerlemans R, Lammertsma AA, Franssen EJ: Effect of age on functional P-glycoprotein in the blood-brain barrier measured by use of (R)-[(11)C]verapamil and positron emission tomography. Clin Pharmacol Ther 2006, 79:540-548.
-
(2006)
Clin Pharmacol Ther
, vol.79
, pp. 540-548
-
-
Toornvliet, R.1
van Berckel, B.N.2
Luurtsema, G.3
Lubberink, M.4
Geldof, A.A.5
Bosch, T.M.6
Oerlemans, R.7
Lammertsma, A.A.8
Franssen, E.J.9
-
19
-
-
33846405283
-
Evaluation of tracer kinetic models for quantification of P-glycoprotein function using (R)-[11C] verapamil and PET
-
Lubberink M, Luurtsema G, van Berckel BN, Boellaard R, Toornvliet R, Windhorst AD, Franssen EJ, Lammertsma AA: Evaluation of tracer kinetic models for quantification of P-glycoprotein function using (R)-[11C] verapamil and PET. J Cereb Blood Flow Metab 2007, 27:424-433.
-
(2007)
J Cereb Blood Flow Metab
, vol.27
, pp. 424-433
-
-
Lubberink, M.1
Luurtsema, G.2
van Berckel, B.N.3
Boellaard, R.4
Toornvliet, R.5
Windhorst, A.D.6
Franssen, E.J.7
Lammertsma, A.A.8
-
20
-
-
70049084419
-
Blood-brain barrier P-glycoprotein function decreases in specific brain regions with aging: A possible role in progressive neurodegeneration
-
Bartels AL, Kortekaas R, Bart J, Willemsen AT, de Klerk OL, de Vries JJ, van Oostrom JC, Leenders KL: Blood-brain barrier P-glycoprotein function decreases in specific brain regions with aging: a possible role in progressive neurodegeneration. Neurobiol Aging 2009, 30:1818-1824.
-
(2009)
Neurobiol Aging
, vol.30
, pp. 1818-1824
-
-
Bartels, A.L.1
Kortekaas, R.2
Bart, J.3
Willemsen, A.T.4
de Klerk, O.L.5
de Vries, J.J.6
van Oostrom, J.C.7
Leenders, K.L.8
-
21
-
-
73349134288
-
A pilot study to assess the efficacy of tariquidar to inhibit P-glycoprotein at the human blood-brain barrier with (R)-11C-verapamil and PET
-
Wagner CC, Bauer M, Karch R, Feurstein T, Kopp S, Chiba P, Kletter K, Loscher W, Muller M, Zeitlinger M, Langer O: A pilot study to assess the efficacy of tariquidar to inhibit P-glycoprotein at the human blood-brain barrier with (R)-11C-verapamil and PET. J Nucl Med 2009, 50:1954-1961.
-
(2009)
J Nucl Med
, vol.50
, pp. 1954-1961
-
-
Wagner, C.C.1
Bauer, M.2
Karch, R.3
Feurstein, T.4
Kopp, S.5
Chiba, P.6
Kletter, K.7
Loscher, W.8
Muller, M.9
Zeitlinger, M.10
Langer, O.11
-
22
-
-
77649273532
-
Assessment of regional differences in tariquidarinduced P-glycoprotein modulation at the human blood-brain barrier
-
Bauer M, Karch R, Neumann F, Wagner CC, Kletter K, Muller M, Loscher W, Zeitlinger M, Langer O: Assessment of regional differences in tariquidarinduced P-glycoprotein modulation at the human blood-brain barrier. J Cereb Blood Flow Metab 2010, 30:510-515.
-
(2010)
J Cereb Blood Flow Metab
, vol.30
, pp. 510-515
-
-
Bauer, M.1
Karch, R.2
Neumann, F.3
Wagner, C.C.4
Kletter, K.5
Muller, M.6
Loscher, W.7
Zeitlinger, M.8
Langer, O.9
-
23
-
-
68249161945
-
Imaging of cyclosporine inhibition of P-glycoprotein activity using 11Cverapamil in the brain: Studies of healthy humans
-
Muzi M, Mankoff DA, Link JM, Shoner S, Collier AC, Sasongko L, Unadkat JD: Imaging of cyclosporine inhibition of P-glycoprotein activity using 11Cverapamil in the brain: studies of healthy humans. J Nucl Med 2009, 50:1267-1275.
-
(2009)
J Nucl Med
, vol.50
, pp. 1267-1275
-
-
Muzi, M.1
Mankoff, D.A.2
Link, J.M.3
Shoner, S.4
Collier, A.C.5
Sasongko, L.6
Unadkat, J.D.7
-
24
-
-
0034500036
-
The blood-brain barrier and oncology: New insights into function and modulation
-
Bart J, Groen HJ, Hendrikse NH, van der Graaf WT, Vaalburg W, de Vries EG: The blood-brain barrier and oncology: new insights into function and modulation. Cancer Treat Rev 2000, 26:449-462.
-
(2000)
Cancer Treat Rev
, vol.26
, pp. 449-462
-
-
Bart, J.1
Groen, H.J.2
Hendrikse, N.H.3
van der Graaf, W.T.4
Vaalburg, W.5
de Vries, E.G.6
-
25
-
-
1842535990
-
Classification analysis of P-glycoprotein substrate specificity
-
Didziapetris R, Japertas P, Avdeef A, Petrauskas A: Classification analysis of P-glycoprotein substrate specificity. J Drug Target 2003, 11:391-406.
-
(2003)
J Drug Target
, vol.11
, pp. 391-406
-
-
Didziapetris, R.1
Japertas, P.2
Avdeef, A.3
Petrauskas, A.4
-
26
-
-
9844227354
-
Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association
-
Brix G, Zaers J, Adam LE, Bellemann ME, Ostertag H, Trojan H, Haberkorn U, Doll J, Oberdorfer F, Lorenz WJ: Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association. J Nucl Med 1997, 38:1614-1623.
-
(1997)
J Nucl Med
, vol.38
, pp. 1614-1623
-
-
Brix, G.1
Zaers, J.2
Adam, L.E.3
Bellemann, M.E.4
Ostertag, H.5
Trojan, H.6
Haberkorn, U.7
Doll, J.8
Oberdorfer, F.9
Lorenz, W.J.10
-
27
-
-
0036937318
-
Fully automated high yield synthesis of (R)-and (S)-[C-11] verapamil for measuring P-glycoprotein function with positron emission tomography
-
Luurtsema G, Windhorst AD, Mooijer MP, Herscheid JD, Lammertsma AA, Franssen EJ: Fully automated high yield synthesis of (R)-and (S)-[C-11] verapamil for measuring P-glycoprotein function with positron emission tomography. J Labelled Compds Radiopharm 2002, 45:1199-1207.
-
(2002)
J Labelled Compds Radiopharm
, vol.45
, pp. 1199-1207
-
-
Luurtsema, G.1
Windhorst, A.D.2
Mooijer, M.P.3
Herscheid, J.D.4
Lammertsma, A.A.5
Franssen, E.J.6
-
28
-
-
0035140276
-
Characteristics of a new fully programmable blood sampling device for monitoring blood radioactivity during PET
-
Boellaard R, van LA, van Balen SC, Hoving BG, Lammertsma AA: Characteristics of a new fully programmable blood sampling device for monitoring blood radioactivity during PET. Eur J Nucl Med 2001, 28:81-89.
-
(2001)
Eur J Nucl Med
, vol.28
, pp. 81-89
-
-
Boellaard, R.1
Van, L.A.2
van Balen, S.C.3
Hoving, B.G.4
Lammertsma, A.A.5
-
29
-
-
13244258485
-
Evaluation of (R)-[11C]verapamil as PET tracer of Pglycoprotein function in the blood-brain barrier: Kinetics and metabolism in the rat
-
Luurtsema G, Molthoff CF, Schuit RC, Windhorst AD, Lammertsma AA, Franssen EJ: Evaluation of (R)-[11C]verapamil as PET tracer of Pglycoprotein function in the blood-brain barrier: kinetics and metabolism in the rat. Nucl Med Biol 2005, 32:87-93.
-
(2005)
Nucl Med Biol
, vol.32
, pp. 87-93
-
-
Luurtsema, G.1
Molthoff, C.F.2
Schuit, R.C.3
Windhorst, A.D.4
Lammertsma, A.A.5
Franssen, E.J.6
-
30
-
-
37849034062
-
Partial volume corrected image derived input functions for dynamic PET brain studies: Methodology and validation for [11C] flumazenil
-
Mourik JE, Lubberink M, Klumpers UM, Comans EF, Lammertsma AA, Boellaard R: Partial volume corrected image derived input functions for dynamic PET brain studies: methodology and validation for [11C] flumazenil. Neuroimage 2008, 39:1041-1050.
-
(2008)
Neuroimage
, vol.39
, pp. 1041-1050
-
-
Mourik, J.E.1
Lubberink, M.2
Klumpers, U.M.3
Comans, E.F.4
Lammertsma, A.A.5
Boellaard, R.6
-
31
-
-
0030740610
-
Use of scanner characteristics in iterative image reconstruction for high-resolution positron emission tomography studies of small animals
-
Brix G, Doll J, Bellemann ME, Trojan H, Haberkorn U, Schmidlin P, Ostertag H: Use of scanner characteristics in iterative image reconstruction for high-resolution positron emission tomography studies of small animals. Eur J Nucl Med 1997, 24:779-786.
-
(1997)
Eur J Nucl Med
, vol.24
, pp. 779-786
-
-
Brix, G.1
Doll, J.2
Bellemann, M.E.3
Trojan, H.4
Haberkorn, U.5
Schmidlin, P.6
Ostertag, H.7
-
32
-
-
76349098446
-
In vivo validation of reconstruction-based resolution recovery for human brain studies
-
Mourik JE, Lubberink M, van Velden FH, Kloet RW, van Berckel BN, Lammertsma AA, Boellaard R: In vivo validation of reconstruction-based resolution recovery for human brain studies. J Cereb Blood Flow Metab 2010, 30:381-389.
-
(2010)
J Cereb Blood Flow Metab
, vol.30
, pp. 381-389
-
-
Mourik, J.E.1
Lubberink, M.2
van Velden, F.H.3
Kloet, R.W.4
van Berckel, B.N.5
Lammertsma, A.A.6
Boellaard, R.7
-
33
-
-
12844261790
-
MR-based automatic delineation of volumes of interest in human brain PET images using probability maps
-
Svarer C, Madsen K, Hasselbalch SG, Pinborg LH, Haugbol S, Frokjaer VG, Holm S, Paulson OB, Knudsen GM: MR-based automatic delineation of volumes of interest in human brain PET images using probability maps. Neuroimage 2005, 24:969-979.
-
(2005)
Neuroimage
, vol.24
, pp. 969-979
-
-
Svarer, C.1
Madsen, K.2
Hasselbalch, S.G.3
Pinborg, L.H.4
Haugbol, S.5
Frokjaer, V.G.6
Holm, S.7
Paulson, O.B.8
Knudsen, G.M.9
-
34
-
-
0032213593
-
Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PET
-
Gunn RN, Sargent PA, Bench CJ, Rabiner EA, Osman S, Pike VW, Hume SP, Grasby PM, Lammertsma AA: Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PET. Neuroimage 1998, 8:426-440.
-
(1998)
Neuroimage
, vol.8
, pp. 426-440
-
-
Gunn, R.N.1
Sargent, P.A.2
Bench, C.J.3
Rabiner, E.A.4
Osman, S.5
Pike, V.W.6
Hume, S.P.7
Grasby, P.M.8
Lammertsma, A.A.9
-
35
-
-
0016355478
-
A new look at the statistical model indentification
-
Akaike H: A new look at the statistical model indentification. IEEE Trans Autom Contr 1974, 19:716-723.
-
(1974)
IEEE Trans Autom Contr
, vol.19
, pp. 716-723
-
-
Akaike, H.1
-
36
-
-
84908219488
-
Statistical methods for assessing agreement between two methods of clinical measurement
-
Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 1:307-310.
-
(1986)
Lancet
, vol.1
, pp. 307-310
-
-
Bland, J.M.1
Altman, D.G.2
|